Detection of TFPI2 methylation in the serum of colorectal cancer patients

Cancer Letters

Volumn 311, Issue 1, 2011, Pages 96-100

  Hibi, Kenji ^a   Goto, Tetsuhiro ^a   Shirahata, Atsushi ^a   Saito, Mitsuo ^a   Kigawa, Gaku ^a   Nemoto, Hiroshi ^a   Sanada, Yutaka ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Colorectal cancer; Methylation; TFPI2

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CARCINOMA; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISTANT METASTASIS; DNA DETERMINATION; DNA METHYLATION; FEMALE; GENE; GENE FREQUENCY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; POORLY DIFFERENTIATED CARCINOMA; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; QUANTITATIVE METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; SERUM; TFPI2 GENE;

ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 80052166888     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.07.006     Document Type: Article

References (22)

1. Leon S.A., Shapiro B., Sklaroff D.M., Yaros M.J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977, 37:646-650.
2. Stroun M., Anker P., Maurice P., Lyautey J., Lederrey C., Beljanski M. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 1989, 46:318-322.
3. Hibi K., Robinson C.R., Booker S., Wu L., Hamilton S.R., Sidransky D., Jen J. Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res. 1998, 58:1405-1407.
4. Mulcahy H.E., Lyautey J., Lederrey C., qi Chen X., Anker P., Alstead E.M., Ballinger A., Farthing M.J., Stroun M. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin. Cancer Res. 1998, 4:271-275.
5. Ito S., Hibi K., Nakayama H., Kodera Y., Ito K., Akiyama S., Nakao A. Detection of tumor DNA in serum of colorectal cancer patients. Jpn. J. Cancer Res. 2002, 93:1266-1269.
6. Uemura T., Hibi K., Kaneko T., Takeda S., Inoue S., Okochi O., Nagasaka T., Nakao A A. Detection of oncogenic mutation in the plasma DNA of pancreatic cancer patients. J. Gastroenterol. 2004, 39:56-60.
7. Hibi K., Nakayama H., Yamazaki T., Takase T., Taguchi M., Kasai Y., Ito K., Akiyama S., Nakao A. Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients. Int. J. Cancer 2001, 94:429-431.
8. Okochi O., Hibi K., Uemura T., Inoue S., Takeda S., Kaneko T., Nakao A. Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. Clin. Cancer Res. 2002, 8:2875-2878.
9. Myohanen S.K., Baylin S.B., Herman J.G. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res. 1998, 58:591-593.
10. Esteller M., Tortola S., Toyota M., Capella G., Peinado M.A., Baylin S.B., Herman J.G. Hypermethylation-associated inactivation of p14 (ARF) is independent of p16 (INK4a) methylation and p53 mutational status. Cancer Res. 2000, 60:129-133.
11. Hibi K., Nakayama H., Kanyama Y., Kodera Y., Ito K., Akiyama S., Nakao A. Methylation pattern of HLTF gene in digestive tract cancers. Int. J. Cancer 2003, 104:433-436.
12. Fujitake S., Hibi K., Okochi O., Kodera Y., Ito K., Akiyama S., Nakao A. Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients. J. Gastroenterol. 2004, 39:120-124.
13. Hibi K., Nakayama H., Kodera Y., Ito K., Akiyama S., Nakao A. CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer. Br. J. Cancer 2004, 90:1030-1033.
14. Nakayama H., Hibi K., Taguchi M., Takase T., Yamazaki T., Kasai Y., Ito K., Akiyama S., Nakao A. Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients. Cancer Lett. 2002, 188:115-119.
15. Glockner S.C., Dhir M., Ti J.M., McGarvey K.E., Neste L.V., Louwagie J., Cahn T.A., Kleeberger W., de Bruine A.P., Smits K.M., Khalid-de Bakker C.A.J., Jonkers D.M.A.E., Stockbrugger R.W., Meijer G.A., Oort F.A., Iacobuzio-Donahue C., Bierau K., Herman J.G., Baylin S.B., Engeland M.V., Schuebel K.E., Ahuja N. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res. 2009, 69:4691-4699.
16. Hibi K., Nakamura H., Hirai A., Fujikake Y., Kasai Y., Akiyama S., Ito K., Takagi H. Loss of H19 imprinting in esophageal cancer. Cancer Res. 1996, 56:480-482.
17. Hibi K., Taguchi M., Nakayama H., Takase T., Kasai Y., Ito K., Akiyama S., Nakao A. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin. Cancer Res. 2001, 7:3135-3138.
18. Esteller M., Sanchez-Cespedes M., Rosell R., Sidransky D., Baylin S.B., Herman J.G. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 1999, 59:67-70.
19. Wong I.H., Lo Y.M., Zhang J., Liew C.T., Ng M.H., Wong N., Lai P.B., Lau W.Y., Hjelm N.M., Johnson P.J. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res. 1999, 59:71-73.
20. Nakayama H., Hibi K., Takase T., Yamazaki T., Kasai Y., Ito K., Akiyama S., Nakao A. Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients. Int. J. Cancer 2003, 105:491-493.
21. Sanchez-Cespedes M., Esteller M., Wu L., Nawroz-Danish H., Yoo G.H., Koch W.M., Jen J., Herman J.G., Sidransky D. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res. 2000, 60:892-895.
22. Vogelstein B., Kinzler K.W. Digital PCR. Proc. Natl Acad. Sci. USA 1999, 96:9236-9241.